Ticker reaction data

Biophytis SA - American Depositary Share (BPTS)

BPTS moved a median of 0.00% 30 minutes after news, and +0.03% by the close. How BPTS actually reacts to news — the realized, point-in-time move the market made, measured across 24 labeled events over the last three years with zero look-ahead.

The quantified answer

BPTS’s median reaction, across the day.

0.00%
Median 30-min
Typical reaction 30 minutes after any BPTS news
46%
Moved up
Share of BPTS news events that rose at 30 minutes
+0.03%
Median to close
Where BPTS typically settles by the closing bell
BPTS median reaction to newsBPTS median reaction to news across 4 horizons: 5-min -0.18%, 30-min +0.00%, 60-min -0.06%, to close +0.03%.5-min30-min60-minto close5-min: -0.18%30-min: +0.00%60-min: -0.06%to close: +0.03%-0.18%+0.00%-0.06%+0.03%-0.18%0+0.03%
Median move vs. the price at the news timestamp, each horizon on its own sample — the counts are in the table below.
BPTS median reaction to news, by horizon. Each rung is measured on the events that traded at that horizon.
HorizonMedian% positiveEvents
5-min-0.18%36%11
30-min0.00%46%13
60-min-0.06%39%13
to close+0.03%54%13

Small sample: only 24 measured events — treat these medians as indicative, not stable.

Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.

Next time, know first

Email me when BPTS moves on news.

One email per qualifying move — the headline, the measured reaction, and how it compares to BPTS's baseline. Nothing else.

▲ BPTS Free · unsubscribe anytime
26M+ news records Operating since 2012 Methodology on SSRN ↗
Latest news

Recent BPTS events, each with its measured reaction.

DateHeadlineEventSource5-minTo close
Biophytis Publishes First-Half Financial Results and Provides an Update on its Business ActivitiesPress releaseAccesswire——
Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in AsiaPress releaseAccesswire——
Biophytis Obtains IND Approval from the FDA to Start its Phase 2 OBA Study in ObesityPress releaseAccesswire——
Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in ParisPress releaseAccesswire——
Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 MillionPress releaseAccesswire——
Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business ActivitiesPress releaseAccesswire——
Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by its Service Provider SeqensPress releaseAccesswire——
Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in ObesityPress releaseAccesswire——
Combined General Meeting of June 24, 2024Press releaseAccesswire——
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in ObesityPress releaseAccesswire——
Biophytis is Deploying its Partnership Strategy in ObesityPress releaseAccesswire——
Biophytis Announces Transfer of ADSs to OTC MarketPress releaseAccesswire+2.93%-0.24%
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) ProgramPress releaseAccesswire+1.72%+0.03%
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in ObesityPress releaseAccesswire+0.17%+12.80%
Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business ActivitiesPress releaseAccesswire-6.93%-7.24%
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)Press releaseAccesswire-6.93%-7.24%
Results of the Combined General Meeting on April 2, 2024Press releaseAccesswire+0.00%+1.15%
Biophytis Presented its Phase 3 Protocol in the Treatment of SarcopeniaPress releaseAccesswire+5.53%+6.08%
Biophytis Announces Receipt of Nasdaq NoticePress releaseAccesswire-3.69%-10.37%
Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in BrazilPress releaseAccesswire—+9.23%
Biophytis Receives Notice of Delisting From Nasdaq and Announces It Will Request a Hearing Before the Nasdaq Hearings PanelPress releaseAccesswire—+9.23%

Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BPTS section they belong to.

Keep exploring

Where else BPTS is measured.

BPTS earnings → · Analyst actions → · SEC filings →

Every ticker we measure the same way24

Apple (AAPL)

How AAPL actually reacts to news, measured.

NVIDIA (NVDA)

How NVDA actually reacts to news, measured.

Tesla (TSLA)

How TSLA actually reacts to news, measured.

Microsoft (MSFT)

How MSFT actually reacts to news, measured.

Advanced Micro Devices (AMD)

How AMD actually reacts to news, measured.

Amazon (AMZN)

How AMZN actually reacts to news, measured.

Alphabet (GOOG)

How GOOG actually reacts to news, measured.

Meta Platforms (META)

How META actually reacts to news, measured.

Broadcom (AVGO)

How AVGO actually reacts to news, measured.

JPMorgan Chase (JPM)

How JPM actually reacts to news, measured.

Visa (V)

How V actually reacts to news, measured.

Walmart (WMT)

How WMT actually reacts to news, measured.

Eli Lilly (LLY)

How LLY actually reacts to news, measured.

UnitedHealth Group (UNH)

How UNH actually reacts to news, measured.

Netflix (NFLX)

How NFLX actually reacts to news, measured.

Johnson & Johnson (JNJ)

How JNJ actually reacts to news, measured.

Exxon Mobil (XOM)

How XOM actually reacts to news, measured.

Home Depot (HD)

How HD actually reacts to news, measured.

Costco (COST)

How COST actually reacts to news, measured.

Mastercard (MA)

How MA actually reacts to news, measured.

Oracle (ORCL)

How ORCL actually reacts to news, measured.

Salesforce (CRM)

How CRM actually reacts to news, measured.

Bank of America (BAC)

How BAC actually reacts to news, measured.

Coca-Cola (KO)

How KO actually reacts to news, measured.

Walt Disney (DIS)

How DIS actually reacts to news, measured.

Browse all tickers

Every name we’ve measured, in one place.

Method

How the numbers are made.

How is Biophytis SA - American Depositary Share's median reaction calculated?

Every labeled BPTS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 24 events is what this page reports. On a sample this small (24 events), treat these medians as indicative, not stable. Point-in-time, zero look-ahead: no event borrows information from a later one.

What counts as a positive reaction?

Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp.

How often is this page updated?

The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.

Does BPTS's past reaction predict its next one?

No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.

Stop guessing what the event means

You just saw one reaction.
There are 26 million more.

For investors

Know the next move, measured.

Ticker alerts with the realized reaction — not the headline spin.

Free · no credit card · unsubscribe anytime
For builders

The dataset, one command away.

claude mcp add news-quantified

Then ask Claude: “how does BPTS react to downgrades?” — or pull it raw via REST.

60-second signup on the NQ portal · 100 free credits/mo
26M+ news records, 2006–2026 Operating since 2012 Point-in-time, zero look-ahead Peer-reviewable methodology (SSRN) ↗